KK
Kelly A. Kramer
Director

Kelly A. Kramer insider trades: Gilead Sciences (GILD) stock sales

Director, Gilead Sciences Last trade Nov 28, 2025 72 Form 4 filings
$713K
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2018
5
Companies
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Kelly reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 28, 2025GILD↓ Sell$713K
Nov 27, 2020CSCO↓ Sell$1.9M
Aug 26, 2020CSCO↓ Sell$1.9M
Feb 27, 2020CSCO↓ Sell$2.9M
Nov 27, 2019CSCO↓ Sell$3.2M
Aug 28, 2019CSCO↓ Sell$3.3M
May 30, 2019CSCO↓ Sell$3.7M
Feb 28, 2019CSCO↓ Sell$3.6M
Nov 29, 2018CSCO↓ Sell$3.3M
Sep 13, 2018CSCO↓ Sell$3.3M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other GILD insiders

Open-market trades in the last 12 months

About Kelly A. Kramer's insider trades

Kelly A. Kramer is a director at Gilead Sciences (GILD). Since Sep 13, 2018, Kelly has reported no open-market purchases and 10 sales worth $27.8M on SEC Form 4. In the last 12 months: 1 sale ($713K).

Their filings also include grants and awards (36 filings), shares withheld for taxes (26 filings), option exercises (9 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every GILD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.